Correlation Between Pfizer and Repligen
Can any of the company-specific risk be diversified away by investing in both Pfizer and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Repligen, you can compare the effects of market volatilities on Pfizer and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Repligen.
Diversification Opportunities for Pfizer and Repligen
Modest diversification
The 3 months correlation between Pfizer and Repligen is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Pfizer i.e., Pfizer and Repligen go up and down completely randomly.
Pair Corralation between Pfizer and Repligen
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.37 times more return on investment than Repligen. However, Pfizer Inc is 2.72 times less risky than Repligen. It trades about 0.0 of its potential returns per unit of risk. Repligen is currently generating about -0.01 per unit of risk. If you would invest 2,628 in Pfizer Inc on December 21, 2024 and sell it today you would lose (9.00) from holding Pfizer Inc or give up 0.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Repligen
Performance |
Timeline |
Pfizer Inc |
Repligen |
Pfizer and Repligen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Repligen
The main advantage of trading using opposite Pfizer and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Repligen vs. Intuitive Surgical | Repligen vs. ResMed Inc | Repligen vs. Merit Medical Systems | Repligen vs. ICU Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |